期刊文献+

生长抑素对胃癌组织中VEGF-C及其受体的影响 被引量:2

The effect of somatostatin (SST) on the expression of vascular endothelial growth factor - C (VEGF - C) and its receptor in gastric cancer
下载PDF
导出
摘要 目的:探讨生长抑素(somatosatain,SST)对胃癌组织中血管内皮生长因子-C(vascular endothelial growth factor-C,VEGF-C)及其受体的影响。方法:将2009年1月-2012年6月行手术治疗的60例胃癌病人按随机序贯方式分为SST治疗组与对照组,每组各30例。用实时荧光定量PCR检测60例胃癌组织及其癌旁组织标本中VEGF-C mRNA表达情况,采用免疫组化方法对其受体Flt-4进行检测。结果:对照组VEGF-C、Flt-4在肿瘤组织与癌旁组织中的表达有显著差异。VEGF-C在肿瘤组织中的表达量与胃癌患者的性别、肿瘤分化程度无关,但与肿瘤的淋巴结转移(P<0.01)、TMN分期(P<0.01)显著相关。SST治疗组与对照组比较,VEGF-C及其受体Flt-4在胃癌组织中的表达水平显著低于对照组(P<0.05)。结论:SST可能通过靶向VEGF-C及其受体抑制胃癌肿瘤淋巴转移。 Objective:To investigate the effect of somatostatin (SST) on the levels of vascular endothelial growth factor-C (VEGF-C) and its receptor in gastric cancer patients.Methods:From January 2009 to June 2012,60 patients undergoing gastrectomy were randomly divided into two groups,SST treatment group (n =30) and control group (n =30).The levels of VEGF-C in tumor tissue and its adjacent tissue were measured by real-time PCR.Meanwhile,we detected its receptor expression by immunohistochemistry.Results:The expressions of VEGF-C and Flt 4 in tumor tissue of control group were significantly higher than those in adjacent tissue (P < 0.05).And the expression of VEGF-C was not correlated with gender,degree of differentiation,but correlated significantly with lymph node metastasis (P < 0.01) and TNM stage (P < 0.01).The expressions of VEGF-C and Flt-4 in SST treatment group were lower than those in control group.Conclusion:SST maybe inhibit the expression of VEGF-C and its receptor in gastric cancer,resulting the inhibition of lymph node metastasis.
出处 《现代肿瘤医学》 CAS 2013年第9期2037-2040,共4页 Journal of Modern Oncology
基金 浦东新区科技发展基金创新资金攻关项目(编号:PKJ2008-Y40)
关键词 胃癌 生长抑素 血管内皮生长因子 gastric cancer somatostatin vascular endothelial growth factor
  • 相关文献

参考文献10

二级参考文献92

共引文献57

同被引文献22

  • 1Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012[J]. CA Cancer J Clin,2015,65~2) :87 - 108.
  • 2Shen L, Shan YS, Hu HM, et al. Management of gastric cancer in Asia : resource - stratified guidelines [ J 1. Lancet Onco1,2013,14(12) :535 - 547.
  • 3Patel YC. Somatostatin and its receptor family [ J ]. Front Neuroendocrinol, 1999,20 ( 3 ) : 157 - 198.
  • 4Holland LJ, Vandamme T, Albertelli M, et al. Hormone and receptor candidates for target and biotherapy of neuroendo- crine tumors[ J ]. Front Horm Res ,2015,44:216 - 238.
  • 5Tejeda M, Gaal D, Hullan L, et al. Evaluation of the antitu- mor efficacy of the somatostatin structural derivative TT - 232 on different tumor models[J]. Anticancer Res,2006,26 (5a) :3477 - 3483.
  • 6Xie Y, Chen S, Wang CH, et al. SOM230 combined with celecoxib prolongs the survival in nude mice with HepG -2 xenografts [ J ]. Cancer Biol Ther,2011,12 ( 1 ) : 86 - 92.
  • 7Theodoropoulou M, Stalla GK. Somatostatin receptors : from signaling to clinical practice [ J ]. Front Neuroendocrinol, 2013,34(3) :228 - 252.
  • 8Folkman J, Shing Y. Angiogenesis [ J ]. J Biol Chem, 1992, 267 ( 16 ) : 10931 - 10934.
  • 9Reinacher - Schick A, Poh! M, Schmiegel W. Drug insight : antiangiogenic therapies for gastrointestinal cancers - focus on monoclonal antibodies [ J ]. Nat Clin Pract Gastroenterol Hepato1,2008,5 ( 5 ) : 250 - 267.
  • 10Dimova I, Popivanov G, Djonov V. Angiogenesis in cancer -general pathways and their therapeutic implications[ J].J buon,2014,19(1):15 -21.

引证文献2

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部